OrthAlign Gets FDA Clearance on ORTHALIGN PLUS

OrthAlign has received 510(k) clearance from the U.S. Food and Drug Administration to market its ORTHALIGN PLUS system.

Advertisement

The system is a palm-sized, single-use navigation device intended for use during total hip arthroplasty and total knee arthroplasty procedures. Additionally, the company’s KNEEALIGN technology will be fully integrated into the OrthAlign Plus system.

 

OrthAlign Plus will be commercially available in fall 2014.

More Articles on Devices:

5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.